{"uri": "eng-9430695", "concepts": [{"uri": "http://en.wikipedia.org/wiki/Multiple_sclerosis", "type": "wiki", "score": 100, "label": {"eng": "Multiple sclerosis"}}, {"uri": "http://en.wikipedia.org/wiki/Royal_Melbourne_Hospital", "type": "wiki", "score": 80, "label": {"eng": "Royal Melbourne Hospital"}}, {"uri": "http://en.wikipedia.org/wiki/Disability", "type": "wiki", "score": 76, "label": {"eng": "Disability"}}, {"uri": "http://en.wikipedia.org/wiki/Diagnosis", "type": "wiki", "score": 60, "label": {"eng": "Diagnosis"}}, {"uri": "http://en.wikipedia.org/wiki/Pediatrics", "type": "wiki", "score": 56, "label": {"eng": "Pediatrics"}}, {"uri": "http://en.wikipedia.org/wiki/Neurology", "type": "wiki", "score": 40, "label": {"eng": "Neurology"}}, {"uri": "http://en.wikipedia.org/wiki/University_of_Melbourne", "type": "org", "score": 32, "label": {"eng": "University of Melbourne"}}, {"uri": "http://en.wikipedia.org/wiki/Fellow", "type": "wiki", "score": 24, "label": {"eng": "Fellow"}}, {"uri": "http://en.wikipedia.org/wiki/Antibody", "type": "wiki", "score": 20, "label": {"eng": "Antibody"}}, {"uri": "http://en.wikipedia.org/wiki/Immune_system", "type": "wiki", "score": 20, "label": {"eng": "Immune system"}}, {"uri": "http://en.wikipedia.org/wiki/Rare_disease", "type": "wiki", "score": 20, "label": {"eng": "Rare disease"}}, {"uri": "http://en.wikipedia.org/wiki/Chronic_condition", "type": "wiki", "score": 12, "label": {"eng": "Chronic condition"}}, {"uri": "http://en.wikipedia.org/wiki/The_Lancet", "type": "wiki", "score": 12, "label": {"eng": "The Lancet"}}, {"uri": "http://en.wikipedia.org/wiki/Spinal_cord", "type": "wiki", "score": 12, "label": {"eng": "Spinal cord"}}, {"uri": "http://en.wikipedia.org/wiki/Brain", "type": "wiki", "score": 12, "label": {"eng": "Brain"}}], "eventDate": "2024-03-25", "totalArticleCount": 5, "title": {"eng": "Global study could change how children with multiple sclerosis are treated"}, "summary": {"eng": "A new study -- the largest of its kind globally -- has found children with multiple sclerosis (MS) have better outcomes if treated early and with the same high-efficacy therapies as adults. The findings were published in Lancet Child and Adolescent Health.\n\nThere are a limited number of therapies approved for children with MS, with only one considered to be of high efficacy -- meaning highly effective.\n\nHowever, a Royal Melbourne Hospital (RMH) observational study has determined that pediatric pa"}, "location": null, "categories": [{"uri": "dmoz/Health/Conditions_and_Diseases/Cardiovascular_Disorders", "label": "dmoz/Health/Conditions and Diseases/Cardiovascular Disorders", "wgt": 100}, {"uri": "dmoz/Health/Conditions_and_Diseases/Digestive_System_Disorders", "label": "dmoz/Health/Conditions and Diseases/Digestive System Disorders", "wgt": 81}, {"uri": "dmoz/Health/Men's_Health/Conditions_and_Diseases", "label": "dmoz/Health/Men's Health/Conditions and Diseases", "wgt": 100}, {"uri": "news/Business", "label": "news/Business", "wgt": 55}], "articleCounts": {"eng": 5}, "sentiment": 0.3647058823529412, "wgt": 449020800, "relevance": 1}